Clival chordoma research
Home › Treatment and outcomes

Recovery timeline after full surgery

Agent report for Kya, 8 September 2026. Scenario: 3.8 cm clival mass, 34-year-old woman, right III and IV and new left VI palsies, basilar partly encased, both cavernous carotids abutted, cavernous sinus involved. Every PMID checked on PubMed E-utilities 8 Sep 2026. UNVERIFIED means standard practice or memory of a full text, not confirmed from an abstract. Evidence levels: L1 randomised trial; L2 systematic review or meta-analysis; L3 large series or registry; L4 small series or review; L5 consensus or clinical judgement.

1. Approach, complications, staging

  1. Endoscopic endonasal (EEA) is now the main route. US National Cancer Database, 736 patients: 62 percent EEA, 38 percent open; survival, 30-day mortality and readmission did not differ; mean stay 2.1 days shorter with EEA. Tumour 4 cm or larger predicted worse survival. Soffer 2024, Neurosurg Focus, PMID 38691856. L3.
  2. EEA vs open, pooled. Komotar 2011 (766 patients): new cranial nerve deficit 1.3 percent endoscopic vs 24.2 percent open; meningitis 0.9 vs 5.9 percent; mortality 4.7 vs 21.6 percent (historic series); CSF leak no different. World Neurosurg, PMID 21986431. L2. Labidi 2016 (1,050 patients): endonasal series had fewer nerve deficits and infections but more CSF leaks; gross total resection 60.7 vs 42.0 percent. J Neurosurg Sci, PMID 27303859. L2.
  3. Modern EEA series. Pittsburgh, 60 patients: CSF leak 20 percent, meningitis 3.3 percent, carotid injury 2 (no deficit), new cranial neuropathy 6.7 percent, long-tract deficit 1.7 percent, no deaths. Koutourousiou 2012, Neurosurgery, PMID 22592328. L3. Bologna, 65 patients: complications 15.1 percent, CSF leak 2.5 percent, transient VI palsy 6.2 percent, carotid injury 2.5 percent (coiled, no deficit), permanent deficit 3.8 percent (one haematoma with hemiparesis, two ophthalmoplegias), no deaths. Zoli 2018, J Neurosurg, PMID 28409727. L3.
  4. Open series. Beijing, 238 patients, 79 percent lateral open: meningitis 8 percent, CSF leak 3.8 percent. Wang 2017, J Neurosurg, PMID 28059654. L3. Historic: CSF leak 30 percent, staged combined approaches 52 percent (Gay 1995, Neurosurgery, PMID 7791978); multi-stage removal 44.5 percent of 74, 2.7 percent died of complications (Tzortzidis 2006, Neurosurgery, PMID 16883163). L3.
  5. Vascular injury. Carotid injury 0.3 percent of 2,015 endonasal operations, but 2 percent of 142 chordoma or chondrosarcoma cases; no stroke; paraclival segment the usual site. Gardner 2013, Neurosurgery, PMID 23695646. L3. Cavernous sinus EEA, 234 patients: carotid injury 4, one death (0.4 percent). Koutourousiou 2017, World Neurosurg, PMID 28450229. L3. No series quantifies basilar injury for chordoma (gap).
  6. Mortality, all endonasal skull base surgery: 0.4 percent of 7,460 (Borg 2016, World Neurosurg, PMID 26960277, L2).
  7. Staging today. Modern EEA series rarely quantify it; historically half of open cases (item 4). For a 3.8 cm tumour into the cavernous sinus a two-stage plan, or planned residual to radiotherapy, is common. L5; ask the unit.

2. Recovery phases

  1. Hospital days. No chordoma-specific figure found (gap). Craniotomy for tumour, 11,510 patients: median 4 days (IQR 3 to 8). Dasenbrock 2015, Neurosurg Focus, PMID 26621410. L3. EEA is about 2 days shorter than open (item 1). Expect 4 to 7 days after an uncomplicated EEA, longer with a lumbar drain, 10 to 14 or more with a leak or meningitis. L5.
  2. Leak, flap and drain. Nasoseptal flap 6.7 percent leak vs 15.6 percent free graft. Harvey 2012, Laryngoscope, PMID 22253060. L2. Randomised trial, lumbar drain after high-flow intradural EEA: leak 8.2 percent with drain vs 21.2 percent without. Zwagerman 2019, J Neurosurg, PMID 30485224. L1. Drain morbidity low (2 of 64 needed blood patches). Birkenbeuel 2022, J Clin Neurosci, PMID 35490574. L3. A drain means 2 to 3 days flat.
  3. Meningitis follows leak. 1.8 percent overall after expanded EEA; 13 percent with a leak vs 0.1 percent without. Lai 2014, J Neurol Surg B, PMID 24498585. L2.
  4. Nasal crusting. 98 percent crust; median 101 days to none, longer for complex cases. de Almeida 2011, Head Neck, PMID 20824807. L3. Sinonasal scores (SNOT-20) are worse after extended approaches at 1, 3 and 6 months; the nasoseptal flap drives a poor 6-month score (OR 4.4). Seo 2019, Laryngoscope, PMID 30569447. L3. Overall quality of life after pituitary EEA recovers by 4 to 6 months (Carmel Neiderman 2022, J Neurol Surg B, PMID 35832941, L3).
  5. Return to activity (pituitary EEA, the best proxy). Basic daily activities within 1 month (median 7 days), instrumental within 2 months (median 15); median 44 days to blow the nose, 59 to lift heavy objects, 64 to wash hair head-down; 73 percent at work by 4 months. Lee 2023, Sci Rep, PMID 36914741. L3. Return to work: median 5 weeks; 39 percent at 1 month, 70 percent at 3, 84 percent overall; long stay and mental health problems delay it. Suzuki 2025, Sci Rep, PMID 41062583. L3. Sick leave stays raised a year on (Krabbe 2026, Eur J Endocrinol, PMID 42594181, L3); women report lower work ability (Uvelius 2017, World Neurosurg, PMID 28860094, L3). Transclival chordoma surgery is bigger: treat these as the floor and add 4 to 8 weeks. L5.
  6. Pain. Mean 4.9 out of 10 on days 0 to 1 after pituitary EEA; 27 percent needed no opioid (Wu 2022, Am J Rhinol Allergy, PMID 34881667, L3). Flap, younger age and anxiety or depression predict more opioid use (Potter 2023, Laryngoscope, PMID 35353373, L3).
  7. Endocrine. Adrenal insufficiency in 1 of 14 in Fatemi 2008 (item 16); pituitary transposition raises the risk. Usual follow-up: cortisol and pituitary panel at 6 weeks and 3 months, then yearly; sodium checks in weeks 1 to 2. L5, UNVERIFIED.

3. Cranial nerve recovery

  1. Natural history of III, IV, VI palsies (206, all causes): 85 percent at least partial recovery, 68 percent complete; deviation angle the only predictor. Park 2008, Eye, PMID 17293794. L3. In 153 patients half recovered within 6 months; the tumour group took longest. Kim 2018, Korean J Ophthalmol, PMID 29770635. L3.
  2. After decompression. 80 percent of cranial neuropathies improved or resolved after endonasal chordoma removal (75 percent of VI). Fatemi 2008, Surg Neurol, PMID 18234296. L4. Cavernous sinus EEA: pre-existing nerve dysfunction improved in 56 percent; intracavernous palsies in 42 percent of non-adenomas. Koutourousiou 2017, PMID 28450229. L3. Improvement runs over 3 to 12 months. L5.
  3. Open lateral approaches can worsen diplopia: 49 percent worse after anterior transpetrosal surgery. Tomio 2024, J Neurosurg, PMID 38277661. L3.
  4. Permanent palsies. 1 in 3 to 1 in 2 long-standing compressive III palsies do not fully recover (items 15, 16). L5.
  5. Diplopia management. Prism or occlusion first; strabismus surgery for III palsy combines recess-resect, transposition, globe fixation and ptosis repair, with more limited results than for VI. Hankinson 2024, Eur J Ophthalmol, PMID 38303488. L4. Surgery waits for 6 to 12 months of stable deviation, normally after radiotherapy. L5, UNVERIFIED.

4. The whole course: surgery to radiotherapy to recovery

  1. Radiotherapy is standard after surgery, protons or carbon ions preferred. Stacchiotti 2015, Lancet Oncol, PMID 25638683; Stacchiotti 2017, Ann Oncol, PMID 28184416. L5 (consensus).
  2. Interval. Usually 6 to 12 weeks after surgery, once the reconstruction has healed and planning scans are done; NHS proton referral adds weeks. L5, UNVERIFIED.
  3. Dose and length. Protons 73.5 Gy(RBE) at 1.8 to 2.0 per fraction (37 to 41 sessions, 7 to 8 weeks). Ares 2009, IJROBP, PMID 19386442. Mean 72.5 Gy(RBE) in 222 patients (Weber 2016, Radiother Oncol, PMID 27247057). Heidelberg: protons 74 Gy(RBE) in 7 weeks or carbon 66 Gy(RBE) in 4 weeks, similar results. Mattke 2023, Strahlenther Onkol, PMID 36149438. Under 48 fared better on carbon (Uhl 2014, Cancer, PMID 24948519). All L3.
  4. Toxicity. 100 chordoma patients on protons: 8 acute grade 3 events (pain 3, dermatitis 2, fatigue, insomnia, dizziness 1 each); no grade 3 late events; fatigue the commonest grade 2 late symptom. Chhabra 2023, Radiother Oncol, PMID 36813169. L3. Freedom from high-grade late toxicity 87 percent at 7 years (Weber 2016). L3. Expect soreness during, 4 to 8 weeks of tiredness after, 3 to 6 months to normal. L5.
  5. Quality of life after protons. Prospective, 77 skull base chordoma and chondrosarcoma: quality of life fell after treatment and recovered from year five; complete resection before protons meant better scores throughout; women scored lower. Bryjova 2025, Cancers, PMID 41301017. L3. In adolescents and young adults it did not fall (Vazquez 2025, Pediatr Blood Cancer, PMID 40682267, L3). Five years after protons for brain tumours fatigue rises while vision and motor symptoms improve (Fessé 2026, J Neurooncol, PMID 42629514, L3).
  6. Reimaging. MRI at about 3 months (the planning scan), then roughly 6-monthly for 5 years and yearly to 10 or 15. L5, UNVERIFIED as a quoted schedule.

5. Patient-reported data for chordoma

  1. Chordoma Foundation survey, 358 patients (40 percent skull base): chronic pain 38 percent, depression or severe anxiety 35 percent, chronic fatigue 34 percent, long-term disability 33 percent, changed career or reduced work 33 percent. Song 2017, Qual Life Res, PMID 28315176. L3 (self-selected). Survivorship survey, 665: emotional or cognitive difficulty 50 percent; needs met for only 41 percent physical, 25 percent emotional, 18 percent social; younger and female survivors reported more. Jimenez 2024, Neurosurg Focus, PMID 38691854. L3. No SF-36 or EQ-5D series for skull base chordoma surgery found (gap); Bryjova (item 24) is the nearest.

6. What lengthens recovery

  1. CSF leak: repair surgery, bed days, 13 percent meningitis (item 10); longer stay and about 15,600 dollars extra cost in pituitary EEA. Parikh 2020, J Neurol Surg B, PMID 32021749. L3.
  2. Staged surgery: two anaesthetics and recoveries, 2 to 8 weeks apart; radiotherapy waits for the second to heal. L5.
  3. Brainstem or basilar work: intradural extension and vessel encasement limit resection (Sen 2010, J Neurosurg, PMID 19929198, L3); long-tract deficit 1.7 percent, haematoma with hemiparesis 1.2 percent (item 3).
  4. Prior deficits: established palsies recover less often than fresh ones (items 15, 16).
  5. Low weight and nutrition: low albumin nearly doubles 30-day mortality odds after craniotomy for tumour (OR 1.9) and raises non-routine discharge (OR 1.5). Dasenbrock 2017, J Neurosurg, PMID 27203139. L3. Albumin was the second strongest predictor of harm in 77,514 cranial operations (Farid 2026, J Clin Neurosci, PMID 42068839, L3). At 51 kg with poor intake this is the modifiable factor; dietitian before surgery.
  6. Opioids: prior use means higher needs and slower bowel and cognition recovery (item 13). L5.
  7. Age: younger patients tolerate more aggressive resection and progress less (Tian 2016, World Neurosurg, PMID 27237421, L3); under 48 did better after carbon ions (item 22).

Summary timeline (clinical judgement from the above)

Surgery 6 to 8 hours; hospital 4 to 7 days (10 to 14 or more if leak); crusting 6 to 8 weeks, no nose blowing 6 weeks, no heavy lifting 8 weeks; self-care in 1 to 2 weeks, out of the house at 3 to 4; tiredness 6 to 12 weeks. Diplopia and ptosis may improve from 6 weeks, mostly over 3 to 12 months; some may not return. Radiotherapy at week 6 to 12, 7 to 8 weeks long, 1 to 2 months of fatigue after. Operation to feeling recovered: 6 to 9 months; staged or complicated, 9 to 12. Non-physical work: 3 to 4 months if all goes well; a third of chordoma patients report lasting effects on work.

What changes: full surgery versus the biopsy described in thread 04

Thread 04 describes a diagnostic endonasal biopsy: 1 to 2 hours, day case or one night, pain 1 to 3 out of 10, crusting 2 to 6 weeks, basic activity within a week, single-digit risk of bleed or leak. Full resection is a different order: 6 to 8 hours or more, sometimes two operations; a nasoseptal flap and often a lumbar drain; 4 to 7 hospital days at best; crusting to about 3 months; CSF leak 2 to 20 percent by unit, with 1 in 8 meningitis if it leaks; carotid injury about 2 percent; new cranial nerve deficit 3 to 7 percent, permanent in 2 to 4 percent; mortality well under 1 percent in modern endoscopic hands. It is also the step that decompresses the nerves (56 to 80 percent improve) and that radiotherapy is built on. Unchanged: no series shows biopsy compromises later resection, and the nutrition, pain and pituitary questions here apply before either procedure.

Research thread 18 · source file em-research/18-recovery-timeline-full-surgery.md · last edited 08 September 2026